Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Insulinoma × Observation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 12 Stomach Neoplasms 11 Prostatic Neoplasms 10 Neoplasms 10 Endometrial Neoplasms 9 Breast Neoplasms 9 Pancreatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Neoplasm Metastasis 6 Oropharyngeal Neoplasms 5 Multiple Myeloma 5 Mouth Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Lung Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Hepatocellular 5 Sarcoma 4 Recurrence 4 Rectal Neoplasms 4 Esophageal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Melanoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Gastrointestinal Stromal Tumors 3 Gallbladder Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Venous Thromboembolism 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Salivary Gland Neoplasms 2

Interventions

fluorodopa F 18 4 Temozolomide 2 Leucovorin 2 Fluorouracil 2 Capecitabine 2 Bevacizumab 2 veliparib 1 vatalanib 1 regorafenib 1 pentetreotide 1 pasireotide 1 Thalidomide 1 Surgical Procedures, Operative 1 Solutions 1 Saline Solution 1 Panobinostat 1 Oxaliplatin 1 Octreotide 1 Observation 1 Irinotecan 1 Injections 1 High-Energy Shock Waves 1 Everolimus 1 Doxorubicin 1 Bortezomib 1 68Ga-NOTA-exendin-4 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07272187 2025-12-09

EURAGIL

Herlev Hospital

Hyperaldosteronism, Insulinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡